prostatic neoplasms
Showing NaN - NaN of 24
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Fullerton, California
- +192 more
Oct 17, 2022
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Prostate Active Surveillance Study
Recruiting
- Prostatic Neoplasms
-
San Francisco, California
- +9 more
Jul 5, 2022
Prostate Cancer, Prostatic Cancer, Prostate Tumors Trial in United States (CyberKnife Stereotactic Radiosurgery)
Active, not recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Phoenix, Arizona
- +22 more
Mar 3, 2021
Carcinoma, Renal Cell, Prostatic Tumors Trial in United Kingdom, United States (FK228 (romidepsin))
Completed
- Carcinoma, Renal Cell
- Prostatic Neoplasms
- FK228 (romidepsin)
-
Duarte, California
- +4 more
Nov 14, 2019
Prostatic Tumors Trial in United States (Radium-223 dichloride (Xofigo, BAY88-8223), Abiraterone acetate, Prednisone)
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Scottsdale, Arizona
- +18 more
Jul 4, 2019
Prostate Cancer, Prostatic Cancer, Prostate Tumors Trial in Seattle (CyberKnife Stereotactic Radiosurgery)
Recruiting
- Prostate Cancer
- +4 more
- CyberKnife Stereotactic Radiosurgery
-
Seattle, WashingtonSwedish Medical Center Radiosurgery Center
Jul 11, 2019
Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Completed
- Advanced Prostate Cancer
- Prostatic Neoplasms
- sipuleucel-T
-
Bessemer, Alabama
- +332 more
Mar 5, 2019
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, mitoxantrone, prednisone)
Prostatic Tumors Trial in United States (epothilone b)
Completed
- Prostatic Neoplasms
- epothilone b
-
Long Beach, California
- +4 more
Feb 7, 2017
Prostatic Tumors Trial in Seattle (Docetaxel, PSKĀ®, Docetaxel, Placebo)
Withdrawn
- Prostatic Neoplasms
- Docetaxel, PSKĀ®
- Docetaxel, Placebo
-
Seattle, WashingtonSeattle Cancer Care Alliance
Oct 23, 2015
Prostatic Tumors Trial in United States (Radium-223 dichloride (BAY88-8223))
No longer available
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Birmingham, Alabama
- +59 more
Jul 11, 2014
Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)
Completed
- Prostatic Neoplasms
- Placebo
- +2 more
-
Birmingham, Alabama
- +127 more
Apr 10, 2014
Prostatic Tumors Trial in Worldwide (Prednisone, sunitinib, Placebo)
Hormone-Refractory Prostate Cancer, Prostatic Tumors Trial in Worldwide (YM598)
Terminated
- Hormone-Refractory Prostate Cancer
- Prostatic Neoplasms
-
Anchorage, Alaska
- +52 more
Jun 6, 2012